A citation-based method for searching scientific literature

Simeon I Taylor, Jenny E Blau, Kristina I Rother, Amber L Beitelshees. Lancet Diabetes Endocrinol 2019
Times Cited: 18







List of co-cited articles
96 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Depression in adults in the T1D Exchange Clinic Registry.
Paula M Trief, Dongyuan Xing, Nicole C Foster, David M Maahs, Julie M Kittelsrud, Beth A Olson, Laura A Young, Anne L Peters, Richard M Bergenstal, Kellee M Miller,[...]. Diabetes Care 2014
40
11



Interindividual Heterogeneity of SGLT2 Expression and Function in Human Pancreatic Islets.
Chiara Saponaro, Markus Mühlemann, Ana Acosta-Montalvo, Anthony Piron, Valery Gmyr, Nathalie Delalleau, Ericka Moerman, Julien Thévenet, Gianni Pasquetti, Anais Coddeville,[...]. Diabetes 2020
17
11

Canagliflozin lowers postprandial glucose and insulin by delaying intestinal glucose absorption in addition to increasing urinary glucose excretion: results of a randomized, placebo-controlled study.
David Polidori, Sue Sha, Sunder Mudaliar, Theodore P Ciaraldi, Atalanta Ghosh, Nicole Vaccaro, Kristin Farrell, Paul Rothenberg, Robert R Henry. Diabetes Care 2013
170
11

SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.
Thomas A Zelniker, Stephen D Wiviott, Itamar Raz, Kyungah Im, Erica L Goodrich, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Remo H M Furtado,[...]. Lancet 2019
830
11

SGLT-2 Inhibitors in Heart Failure: Current Management, Unmet Needs, and Therapeutic Prospects.
Carolyn S P Lam, Chanchal Chandramouli, Vineeta Ahooja, Subodh Verma. J Am Heart Assoc 2019
40
11

2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
John B Buse, Deborah J Wexler, Apostolos Tsapas, Peter Rossing, Geltrude Mingrone, Chantal Mathieu, David A D'Alessio, Melanie J Davies. Diabetologia 2020
116
11

ISPAD Clinical Practice Consensus Guidelines 2018: Exercise in children and adolescents with diabetes.
Peter Adolfsson, Michael C Riddell, Craig E Taplin, Elizabeth A Davis, Paul A Fournier, Francesca Annan, Andrea E Scaramuzza, Dhruvi Hasnani, Sabine E Hofer. Pediatr Diabetes 2018
52
11

A randomized study and open-label extension evaluating the long-term efficacy of pramlintide as an adjunct to insulin therapy in type 1 diabetes.
Fred Whitehouse, Davida F Kruger, Mark Fineman, Larry Shen, James A Ruggles, David G Maggs, Christian Weyer, Orville G Kolterman. Diabetes Care 2002
169
11

Effects of exenatide alone and in combination with daclizumab on beta-cell function in long-standing type 1 diabetes.
Kristina I Rother, Lisa M Spain, Robert A Wesley, Benigno J Digon, Alain Baron, Kim Chen, Patric Nelson, H-Michael Dosch, Jerry P Palmer, Barbara Brooks-Worrell,[...]. Diabetes Care 2009
88
11

ISPAD Clinical Practice Consensus Guidelines 2018: Nutritional management in children and adolescents with diabetes.
Carmel E Smart, Francesca Annan, Laurie A Higgins, Elisabeth Jelleryd, Mercedes Lopez, Carlo L Acerini. Pediatr Diabetes 2018
47
11


Biopsychosocial Aspects of Weight Management in Type 1 Diabetes: a Review and Next Steps.
Kimberly A Driscoll, Karen D Corbin, David M Maahs, Richard Pratley, Franziska K Bishop, Anna Kahkoska, Korey K Hood, Elizabeth Mayer-Davis. Curr Diab Rep 2017
23
11

Insulin's direct effects on the liver dominate the control of hepatic glucose production.
Dale S Edgerton, Margaret Lautz, Melanie Scott, Carrie A Everett, Kathryn M Stettler, Doss W Neal, Chang A Chu, Alan D Cherrington. J Clin Invest 2006
113
11

Impact of Excessive Weight Gain on Cardiovascular Outcomes in Type 1 Diabetes: Results From the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.
Jonathan Q Purnell, Barbara H Braffett, Bernard Zinman, Rose A Gubitosi-Klug, William Sivitz, John P Bantle, Georgia Ziegler, Patricia A Cleary, John D Brunzell. Diabetes Care 2017
38
11

Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry.
Kellee M Miller, Nicole C Foster, Roy W Beck, Richard M Bergenstal, Stephanie N DuBose, Linda A DiMeglio, David M Maahs, William V Tamborlane. Diabetes Care 2015
719
11

The use of metformin in type 1 diabetes: a systematic review of efficacy.
S Vella, L Buetow, P Royle, S Livingstone, H M Colhoun, J R Petrie. Diabetologia 2010
111
11

Control of Postprandial Hyperglycemia in Type 1 Diabetes by 24-Hour Fixed-Dose Coadministration of Pramlintide and Regular Human Insulin: A Randomized, Two-Way Crossover Study.
Matthew C Riddle, Rajaa Nahra, Jenny Han, Jessica Castle, Kathryn Hanavan, Marcus Hompesch, David Huffman, Poul Strange, Peter Öhman. Diabetes Care 2018
15
13

A Novel Dual-Hormone Insulin-and-Pramlintide Artificial Pancreas for Type 1 Diabetes: A Randomized Controlled Crossover Trial.
Ahmad Haidar, Michael A Tsoukas, Sarah Bernier-Twardy, Jean-Francois Yale, Joanna Rutkowski, Anne Bossy, Evelyne Pytka, Anas El Fathi, Natalia Strauss, Laurent Legault. Diabetes Care 2020
27
11

Effect of adjunct metformin treatment in patients with type-1 diabetes and persistent inadequate glycaemic control. A randomized study.
Søren Søgaard Lund, Lise Tarnow, Anne Sofie Astrup, Peter Hovind, Peter Karl Jacobsen, Amra Ciric Alibegovic, Ida Parving, Lotte Pietraszek, Merete Frandsen, Peter Rossing,[...]. PLoS One 2008
53
11

Use of Adjuvant Pharmacotherapy in Type 1 Diabetes: International Comparison of 49,996 Individuals in the Prospective Diabetes Follow-up and T1D Exchange Registries.
Sarah K Lyons, Julia M Hermann, Kellee M Miller, Sabine E Hofer, Nicole C Foster, Birgit M Rami-Merhar, Grazia Aleppo, Jochen Seufert, Linda A DiMeglio, Thomas Danne,[...]. Diabetes Care 2017
29
11


Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C): a randomised, double-blind, placebo-controlled trial.
Nicklas J Johansen, Thomas F Dejgaard, Asger Lund, Camilla Schlüntz, Christian S Frandsen, Julie L Forman, Nicolai J Wewer Albrechtsen, Jens J Holst, Ulrik Pedersen-Bjergaard, Sten Madsbad,[...]. Lancet Diabetes Endocrinol 2020
9
22

Effect of Metformin Added to Insulin on Glycemic Control Among Overweight/Obese Adolescents With Type 1 Diabetes: A Randomized Clinical Trial.
Ingrid M Libman, Kellee M Miller, Linda A DiMeglio, Kathleen E Bethin, Michelle L Katz, Avni Shah, Jill H Simmons, Michael J Haller, Sripriya Raman, William V Tamborlane,[...]. JAMA 2015
91
11

Effect of sitagliptin on post-prandial glucagon and GLP-1 levels in patients with type 1 diabetes: investigator-initiated, double-blind, randomized, placebo-controlled trial.
Satish K Garg, Emily G Moser, Bruce W Bode, Leslie J Klaff, William R Hiatt, Christie Beatson, Janet K Snell-Bergeon. Endocr Pract 2013
66
11

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Hertzel C Gerstein, Helen M Colhoun, Gilles R Dagenais, Rafael Diaz, Mark Lakshmanan, Prem Pais, Jeffrey Probstfield, Jeffrey S Riesmeyer, Matthew C Riddle, Lars Rydén,[...]. Lancet 2019
514
11

Verapamil and beta cell function in adults with recent-onset type 1 diabetes.
Fernando Ovalle, Tiffany Grimes, Guanlan Xu, Anish J Patel, Truman B Grayson, Lance A Thielen, Peng Li, Anath Shalev. Nat Med 2018
31
11

Preventing β-cell loss and diabetes with calcium channel blockers.
Guanlan Xu, Junqin Chen, Gu Jing, Anath Shalev. Diabetes 2012
88
11

Use of Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Type 1 Diabetes and Rates of Diabetic Ketoacidosis.
Christian Hampp, Richard S Swain, Casie Horgan, Elizabeth Dee, Yandong Qiang, Sarah K Dutcher, Andrew Petrone, Rong Chen Tilney, Judith C Maro, Catherine A Panozzo. Diabetes Care 2020
14
14


Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial.
Paresh Dandona, Chantal Mathieu, Moshe Phillip, Lars Hansen, Steven C Griffen, Diethelm Tschöpe, Fredrik Thorén, John Xu, Anna Maria Langkilde. Lancet Diabetes Endocrinol 2017
145
11

Empagliflozin as adjunct to insulin in patients with type 1 diabetes: a 4-week, randomized, placebo-controlled trial (EASE-1).
T R Pieber, S Famulla, J Eilbracht, J Cescutti, N Soleymanlou, O E Johansen, H J Woerle, U C Broedl, S Kaspers. Diabetes Obes Metab 2015
99
11

Glucose Variables in Type 1 Diabetes Studies With Dapagliflozin: Pooled Analysis of Continuous Glucose Monitoring Data From DEPICT-1 and -2.
Chantal Mathieu, Paresh Dandona, Moshe Phillip, Tal Oron, Marcus Lind, Lars Hansen, Fredrik Thorén, John Xu, Anna Maria Langkilde. Diabetes Care 2019
22
11

Hypoglycemia and risk of cardiovascular disease and all-cause mortality in insulin-treated people with type 1 and type 2 diabetes: a cohort study.
Kamlesh Khunti, Melanie Davies, Azeem Majeed, Brian Larsen Thorsted, Michael Lyng Wolden, Sanjoy K Paul. Diabetes Care 2015
166
11

Remogliflozin etabonate, a selective inhibitor of the sodium-glucose transporter 2, improves serum glucose profiles in type 1 diabetes.
Sunder Mudaliar, Debra A Armstrong, Annie A Mavian, Robin O'Connor-Semmes, Patricia K Mydlow, June Ye, Elizabeth K Hussey, Derek J Nunez, Robert R Henry, Robert L Dobbins. Diabetes Care 2012
32
11

Prevalence of overweight and obesity in youth with diabetes in USA: the SEARCH for Diabetes in Youth study.
Lenna L Liu, Jean M Lawrence, Cralen Davis, Angela D Liese, David J Pettitt, Catherine Pihoker, Dana Dabelea, Richard Hamman, Beth Waitzfelder, Henry S Kahn. Pediatr Diabetes 2010
190
11

Effects of dapagliflozin on insulin-requirement, glucose excretion and ß-hydroxybutyrate levels are not related to baseline HbA1c in youth with type 1 diabetes.
Torben Biester, Baerbel Aschemeier, Maryam Fath, Marcel Frey, Markus F Scheerer, Olga Kordonouri, Thomas Danne. Diabetes Obes Metab 2017
18
11

International Consensus on Use of Continuous Glucose Monitoring.
Thomas Danne, Revital Nimri, Tadej Battelino, Richard M Bergenstal, Kelly L Close, J Hans DeVries, Satish Garg, Lutz Heinemann, Irl Hirsch, Stephanie A Amiel,[...]. Diabetes Care 2017
536
11

Closed-loop glucose control in young people with type 1 diabetes during and after unannounced physical activity: a randomised controlled crossover trial.
Klemen Dovc, Maddalena Macedoni, Natasa Bratina, Dusanka Lepej, Revital Nimri, Eran Atlas, Ido Muller, Olga Kordonouri, Torben Biester, Thomas Danne,[...]. Diabetologia 2017
32
11

Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet.
Iris Shai, Dan Schwarzfuchs, Yaakov Henkin, Danit R Shahar, Shula Witkow, Ilana Greenberg, Rachel Golan, Drora Fraser, Arkady Bolotin, Hilel Vardi,[...]. N Engl J Med 2008
928
11

Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes.
Sue A Brown, Boris P Kovatchev, Dan Raghinaru, John W Lum, Bruce A Buckingham, Yogish C Kudva, Lori M Laffel, Carol J Levy, Jordan E Pinsker, R Paul Wadwa,[...]. N Engl J Med 2019
146
11

Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials.
Roy W Beck, Richard M Bergenstal, Tonya D Riddlesworth, Craig Kollman, Zhaomian Li, Adam S Brown, Kelly L Close. Diabetes Care 2019
170
11

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range.
Tadej Battelino, Thomas Danne, Richard M Bergenstal, Stephanie A Amiel, Roy Beck, Torben Biester, Emanuele Bosi, Bruce A Buckingham, William T Cefalu, Kelly L Close,[...]. Diabetes Care 2019
491
11

Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.
Stuart A Weinzimer, Garry M Steil, Karena L Swan, Jim Dziura, Natalie Kurtz, William V Tamborlane. Diabetes Care 2008
298
11


Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies.
Hertzel C Gerstein, Pasqualina Santaguida, Parminder Raina, Katherine M Morrison, Cynthia Balion, Dereck Hunt, Hossein Yazdi, Lynda Booker. Diabetes Res Clin Pract 2007
302
5

Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial.
Maud Robert, Philippe Espalieu, Elise Pelascini, Robert Caiazzo, Adrien Sterkers, Lita Khamphommala, Tigran Poghosyan, Jean-Marc Chevallier, Vincent Malherbe, Elie Chouillard,[...]. Lancet 2019
100
5

EndoBarrier®: a Safe and Effective Novel Treatment for Obesity and Type 2 Diabetes?
Nisha Patel, Aruchuna Mohanaruban, Hutan Ashrafian, Carel Le Roux, James Byrne, John Mason, James Hopkins, Jamie Kelly, Julian Teare. Obes Surg 2018
12
8

The Effect of Bariatric Surgery on Peripheral Polyneuropathy: a Systematic Review and Meta-analysis.
Rokhsareh Aghili, Mojtaba Malek, Kiarash Tanha, Azadeh Mottaghi. Obes Surg 2019
5
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.